Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,854 GBX | +2.26% | +3.63% | +3.63% |
11:16am | Hikma Pharmaceuticals backs outlook after making strong start to 2024 | AN |
09:16am | Hikma Pharmaceuticals Affirms FY24 Guidance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.63% | 5B | |
+24.17% | 562B | |
-6.27% | 358B | |
+20.05% | 322B | |
+7.92% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.58% | 149B | |
-6.40% | 146B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals : Pauses Asthma Drug Launch to Amend US FDA Application